Biopharmaceuticals Development

Genetix announces the launch of their next generation mammalian cell imaging and picking instrument, the ClonePix FL. The instrument is being launched at LabAutomation in San Jose, California. The instrument builds upon the success of the ClonePix, the first instrument developed to target one of the major bottlenecks of biopharmaceutical development. The new instrument adds fluorescent capabilities to the ability to pick antibody producing clones. It enables the
selection of cells using quantitative measurements based on
the pharmacological properties of affinity and specificity, the criteria that determine whether a drug will succeed or fail.